Allan Evans

Prof Allan Evans

Chancellery and Council Services

Chancellery

Allan graduated in 1982 with a Bachelor of Pharmacy at the South Australian Institute of Technology, UniSA’s antecedent institution. In 1989, he obtained his PhD in clinical pharmacology from the University of Adelaide. He followed this with post-doctoral experience at the University of Manchester, UK.
Allan has been an academic at UniSA for over 25 years, taking on various leadership positions including Senior Lecturer and Associate Professor. He was promoted to Professor in Pharmaceutics in 2003. The following year, he became Head of the School of Pharmacy and Medical Sciences, where he was instrumental in establishing the Sansom Institute (now the Division-based Sansom Institute for Health Research) and in supporting tremendous growth in the School’s research activity and teaching profile. In 2009, he became Pro Vice Chancellor and Vice President: Division of Health Sciences. Through his leadership, the Division registered significant growth in student numbers and experienced sustained improvement in research activity. From 2013 - 2021, Allan was UniSA’s inaugural Provost & Chief Academic Officer. As Provost, he was responsible for enhancing UniSA’s educational offerings, providing an outstanding student experience, and planning and development of the University’s academic programs. Allan has launched a whole-of-University review of the curriculum to examine the overall disciplinary profile of each School focusing on teaching quality, student engagement and satisfaction, and the uptake of the University’s blended and external delivery.
Allan has a significant research career. He has more than 100 peer-reviewed publications with over 1,400 literature citations and has held NHMRC and/or ARC grants on an ongoing basis since 1994. His research interests are broad, and include basic, clinical and commercial research into the better use of medicines as well as the development of new ways of using medicines to treat skin cancer and kidney disease. Allan’s group has attracted over $15 million in Category 1-4 research income to UniSA. Allan is former President of the Australasian Pharmaceutical Science Association (APSA) and winner of the APSA medal for outstanding contributions to pharmaceutical science.
Allan previously served as non-executive Director of CPR Pharma Services Ltd, a spin-off company that he helped to form in 2009. He has a keen interest in supporting innovation in the health and medical sector and encouraging entrepreneurial activity within UniSA.

  • Carnitine - its role in maintaining skeletal and cardiac function and its pharmacokinetics
  • Pharmacokinetics - modeling, statistics, simulation and prediction
  • Drug absorption - oral, transdermal and mucoadhesive drug delivery systems
  • Cancer prevention - skin cancer prevention using novel compounds
  • Drug development - streamlining pharmaceutical development of novel dosage forms
  • The placebo response

Year Citation
2025 Meola, T. R., Ludbrook, G., Fornasini, G., Pavlova, O., Jain, S., Evans, A. M., & Reuter, S. E. (2025). Absolute bioavailability and intravenous pharmacokinetics of N-acetyl-D-mannosamine in humans. British Journal of Clinical Pharmacology, online, 1-7.
DOI
2024 Evans, A. M., Fornasini, G., Meola, T. R., Gahl, W. A., Huizing, M., Polasek, T. M., & Reuter, S. E. (2024). Impact of Food on the Oral Absorption of N-Acetyl-D-Mannosamine in Healthy Men and Women. Clinical Pharmacology in Drug Development, 13(8), 876-883.
DOI Scopus2 WoS2 Europe PMC2
2021 Reuter, S. E., Schultz, H. B., Ward, M. B., Grant, C. L., Paech, G. M., Banks, S., & Evans, A. M. (2021). The effect of high-dose, short-term caffeine intake on the renal clearance of calcium, sodium and creatinine in healthy adults. British Journal of Clinical Pharmacology, 87(11), 4461-4466.
DOI Scopus15 WoS13 Europe PMC13
2019 Milliken, E., de Zwart, A. E. S., Alffenaar, J. W. C., Marriott, D. J. E., Riezebos Brilman, A., Schteinman, A., . . . Reuter, S. E. (2019). Population pharmacokinetics of ribavirin in lung transplant recipients and examination of current and alternative dosing regimens. Journal of antimicrobial chemotherapy, 74(3), 691-698.
DOI Scopus4 WoS4 Europe PMC4
2019 Reuter, S. E., Evans, A. M., & Ward, M. B. (2019). Reducing palivizumab dose requirements through rational dose regimen design. CPT: pharmacometrics and systems pharmacology, 8(1), 26-33.
DOI Scopus3 WoS4 Europe PMC6
2015 Reuter, S., Evans, A., Shakib, S., Lungershausen, Y., Francis, B., Valentini, G., . . . Pace, S. (2015). Effect of food on the pharmacokinetics of piperaquine and dihydroartemisinin. Clinical Drug Investigation, 35(9), 559-567.
DOI Scopus27 WoS26 Europe PMC24
2014 Westley, I., Coller, J., Ward, M., Evans, A., Morris, R., & Sallustio, B. (2014). A primer extension denaturing high-performance liquid chromatography method for the identification of three ABCC2 genetic polymorphisms. Journal of Liquid Chromatography and Related Technologies, 37(9), 1249-1256.
DOI
2014 Reuter, S., Upton, R., Evans, A., Navaratnam, V., & Olliaro, P. (2014). Population pharmacokinetics of orally administered mefloquine in healthy volunteers and patients with uncomplicated Plasmodium falciparum malaria. Journal of Antimicrobial Chemotherapy, 70(3), 868-876.
DOI Scopus17 WoS17 Europe PMC15
2014 Davis, S. R., Evans, A. M., & Humberstone, A. (2014). Application site affects the pharmacokinetics of topical testosterone applied to the axilla compared with the inner arm. Clinical therapeutics, 36(10), 1395-1401.
DOI Scopus1 WoS2
2013 Reuter, S., & Evans, A. (2013). What is the value of l-carnitine level determination for carnitine supplementation in hemodialysis patients?. Hemodialysis International, 17(3), 335-338.
DOI Scopus1 WoS1 Europe PMC1
2013 Schultz, S. J., Hotham, E. D., & Evans, A. M. (2013). Australian pharmacists' uncertainty about homeopathic products in community pharmacy. Focus on alternative and complementary therapies, 19(1), 9-15.
DOI Scopus4
2012 Reuter, S. E., & Evans, A. M. (2012). Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects. Clinical pharmacokinetics, 51(9), 553-572.
DOI WoS399
2012 Wiese, M., Sluggett, J., Wilson, C., Reuter, S., Turner, S., & Evans, A. (2012). Perceived and actual paracetamol dosing in overweight and obese children. EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE, 19(5), 438-442.
DOI Scopus2 WoS2
2012 Reuter, S. E., & Evans, A. M. (2012). Carnitine and acylcarnitines: Pharmacokinetic, pharmacological and clinical aspects. Clinical Pharmacokinetics, 51(9), 553-572.
DOI Scopus417 Europe PMC341
2011 Rao, S., Song, Y., Peddie, F., & Evans, A. M. (2011). Particle size reduction to the nanometer range: a promising approach to improve buccal absorption of poorly water-soluble drugs. International journal of nanomedicine, 6, 1245-1251.
DOI Scopus92 WoS83 Europe PMC52
2011 Rao, S., Song, Y., Peddie, F., & Evans, A. M. (2011). A novel tri-layered buccal mucoadhesive patch for drug delivery: assessment of nicotine delivery. Journal of pharmacy and pharmacology, 63(6), 794-799.
DOI Scopus15 WoS11 Europe PMC8
2011 Reuter, L. S. E., Massy Westropp, N. M., & Evans, A. M. (2011). Reliability and validity of indices of hand-grip strength and endurance. Australian occupational therapy journal, 58(2), 82-87.
DOI Scopus58 WoS52 Europe PMC43
2011 Uchaipichat, V., Raungrut, P., Chau, N., Janchawee, B., Evans, A. M., & Miners, J. O. (2011). Effects of ketamine on human UDP-glucuronosyltransferases in vitro predict potential drug-drug interactions arising from ketamine inhibition of codeine and morphine glucuronidation. Drug metabolism and disposition, 39(8), 1324-1328.
DOI Scopus38 WoS33 Europe PMC27
2011 Reuter, S. E., & Evans, A. M. (2011). Long-chain acylcarnitine deficiency in patients with chronic fatigue syndrome. Potential involvement of altered carnitine palmitoyltransferase-I activity. Journal of internal medicine, 270(1), 76-84.
DOI Scopus41 WoS36 Europe PMC34
2011 Wang, J., Evans, A. M., Knights, K. M., & Miners, J. O. (2011). Differential disposition of intra-renal generated and preformed glucuronides: studies with 4-methylumbelliferone and 4-methylumbelliferyl glucuronide in the filtering and nonfiltering isolated perfused rat kidney. Journal of pharmacy and pharmacology, 63(4), 507-514.
DOI Scopus11 WoS8 Europe PMC6
2010 Olliaro, P., Ramanathan, S., Vaillant, M., Reuter, L. S. E., Evans, A. M., Krudsood, S., . . . Navaratnam, V. (2010). Pharmacokinetics and comparative bioavailability of artesunate and mefloquine administered separately or as a fixed combination product to healthy volunteers and patients with uncomplicated plasmodium falciparum malaria. Journal of bioequivalence and bioavailability, 2(3), 59-66.
DOI
2010 Qi, X., Evans, A. M., Wang, J., Miners, J. O., Upton, R. N., & Milne, R. W. (2010). Inhibition of morphine metabolism by ketamine. Drug metabolism and disposition, 38(5), 728-731.
DOI Scopus30 WoS25 Europe PMC22
2009 Reuter, S., Faull, R., Ranieri, E., & Evans, A. (2009). Endogenous plasma carnitine pool composition and response to erythropoietin treatment in chronic haemodialysis patients. Nephrology Dialysis Transplantation, 24(3), 990-996.
DOI Scopus35 WoS33 Europe PMC26
2009 Ward, M. B., Sorich, M. J., Evans, A. M., & McKinnon, R. A. (2009). Cytochrome P450 part 3: Impact of drug-drug interactions. Journal of pharmacy practice and research, 39(1), 55-58.
DOI Scopus5
2008 Reuter, S., Faull, R., & Evans, A. (2008). L-carnitine supplementation in the dialysis population: Are Australian patients missing out?. Nephrology, 13(1), 3-16.
DOI Scopus29 WoS29 Europe PMC18
2008 Westley, I., Morris, R., Evans, A., & Sallustio, B. (2008). Glucuronidation of mycophenolic acid by Wistar and Mrp2-deficient TR- rat liver microsomes. Drug Metabolism and Disposition, 36(1), 46-50.
DOI Scopus7 WoS7 Europe PMC6
2008 Reuter, L. S. E., Evans, A. M., Chace, D., & Fornasini, G. (2008). Determination of the reference range of endogenous plasma carnitines in healthy adults. Annals of Clinical Biochemistry, 45(6), 585-592.
DOI Scopus52 WoS50 Europe PMC35
2007 Bazargan, M., Gerber, J. P., Wang, J., Chitsaz, M., Milne, R. W., & Evans, A. M. (2007). Determination of isosteviol by LC-MS/MS and its application for evaluation of pharmacokinetics of isosteviol in rat. DARU, 15(3), 146-150.
Scopus5 WoS5
2007 Xia, W., Hsu, H. Y., Kong, L., Evans, A. M., & Lee, R. (2007). A potential application of a piezoelectric atomizer for ophthalmic drug delivery. Applied Bionics and Biomechanics, 4(1), 9-17.
DOI Scopus1
2007 Fornasini, G., Upton, R., & Evans, A. (2007). A pharmacokinetic model for L-carnitine in patients receiving haemodialysis. British Journal of Clinical Pharmacology, 64(3), 335-345.
DOI Scopus26 WoS23 Europe PMC18
2007 Xu, D., Li, Y., Wang, J., Davey, A. K., Zhang, S., & Evans, A. M. (2007). The cardioprotective effect of isosteviol on rats with heart ischemia-reperfusion injury. Life sciences, 80(4), 269-274.
DOI Scopus57 WoS50 Europe PMC37
2007 Ma, J., Ma, Z., Wang, J., Milne, R. W., Xu, D., Davey, A. K., & Evans, A. M. (2007). Isosteviol reduces plasma glucose levels in the intravenous glucose tolerance test in Zucker diabetic fatty rats. Diabetes, obesity and metabolism, 9(4), 597-599.
DOI Scopus61 WoS57 Europe PMC32
2006 Bain, M., Faull, R., Fornasini, G., Milne, R., & Evans, A. (2006). Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis. Nephrology Dialysis Transplantation, 21(5), 1300-1304.
DOI Scopus246 WoS233 Europe PMC192
2006 Westley, I., Brogan, L., Morris, R., Evans, A., & Sallustio, B. (2006). Role of MRP2 in the hepatic disposition of mycophenolic acid and its glucuronide metabolites: Effect of cyclosporine. Drug Metabolism and Disposition, 34(2), 261-266.
DOI Scopus99 WoS95 Europe PMC82
2006 Bain, M., Faull, R., Milne, R., & Evans, A. (2006). Oral L-carnitine: Metabolite formation and hemodialysis. Current Drug Metabolism, 7(7), 811-816.
DOI Scopus25 WoS20 Europe PMC18
2006 Wang, J., Nation, R., Evans, A. M., Cox, S., & Li, J. (2006). Determination of antiviral nucleoside analogues AM365 and AM188 in perfusate and bile of the isolated perfused rat liver using HPLC. Biomedical chromatography, 20(3), 244-250.
DOI Scopus4 WoS4 Europe PMC3
2006 Davey, A. K., Evans, A. M., & Stupans, I. (2006). Pharmacy Factors that influence the choice of career and study options. Pharmacy Education, 6(1), 21-26.
DOI Scopus20
2006 Angley, M. T., McKinnon, R. A., Young, R. L., & Evans, A. M. (2006). Children and autism can the pharmacist help?. Australian Pharmacist.
2006 Bain, M. A., Milne, R. W., & Evans, A. M. (2006). Disposition and metabolite kinetics of oral L-carnitine in humans. The Journal of Clinical Pharmacology, 46(10), 1163-1170.
DOI Scopus40 WoS38 Europe PMC26
2006 Bremmell, K. E., Evans, A. M., & Prestidge, C. A. (2006). Deformation and nano-rheology of red blood cells. Colloids and surfaces B : biointerfaces, 50(1), 43-48.
DOI Scopus78 WoS69 Europe PMC42
2006 Shackleford, D. M., Evans, A. M., Milne, R. W., & Nation, R. (2006). Loading-washout studies of the stereoselective sinusoidal uptake of (R)-and (S)-2 phenylpropionyl acyl glucuronide. Current drug metabolism, 7(7), 817-826.
DOI
2005 Davison, S., Thippawong, J., Blanchard, J., Lui, K., Morishige, R., Gonda, I., . . . Davis, S. (2005). Pharmacokinetics and acute safety of inhaled testosterone in postmenopausal women. Journal of Clinical Pharmacology, 45(2), 177-184.
DOI Scopus36 WoS30 Europe PMC23
2005 Wang, J., Nation, R., Evans, A. M., Cox, S., & Shackleford, D. (2005). Metabolism and disposition of the antiviral nucleoside analogue AM365 in the isolated perfused rat liver. Current drug metabolism, 6(5), 487-493.
DOI Scopus1 WoS1
2005 Bain, M. A., Fornasini, G., & Evans, A. M. (2005). Trimethylamine: metabolic, pharmacokinetic and safety aspects. Current drug metabolism, 6(3), 227-240.
DOI Scopus82 WoS81 Europe PMC63
2005 Mancinelli, A., Evans, A. M., Nation, R., & Longo, A. (2005). Uptake of L-carnitine and its short-chain ester propionyl-L-carnitine in the isolated perfused rat liver. Journal of Pharmacology and Experimental Therapeutics, 315(1), 118-124.
DOI Scopus4 WoS3 Europe PMC4
2005 Reuter, S., Evans, A., Faull, R., Chace, D., & Fornasini, G. (2005). Impact of haemodialysis on individual endogenous plasma acylcarnitine concentrations in end-stage renal disease. Annals of Clinical Biochemistry, 42(PN Part 5), 387-393.
DOI Scopus33 WoS30 Europe PMC22
2005 Reuter, S. E., Evans, A. M., & Fornasini, G. (2005). Reply from the Authors [2]. Kidney International, 68(3), 1368-1369.
DOI
2005 Reuter, S. E., Evans, A. M., & Fornasini, G. (2005). Changes in the composition of carnitines in hemodialysis patients - Reply. KIDNEY INTERNATIONAL, 68(3), 1368-1369.
2005 Yen, T. T., Agatonovic Kustrin, S., Evans, A. M., Nation, R., & Ryand, J. (2005). Prediction of drug absorption based on immobilized artificial membrane (IAM) chromatography separation and calculated molecular descriptors. Journal of pharmaceutical and biomedical analysis, 38(3), 472-478.
DOI Scopus51 WoS45 Europe PMC31
2004 Wang, J., Nation, R., Evans, A. M., & Cox, S. (2004). Renal secretion of the antiviral nucleoside analog AM188 is inhibited by probenecid, p-aminohippuric acid, and cimetidine in the isolated perfused rat kidney. Pharmaceutical research, 21(6), 982-988.
DOI Scopus5 WoS5 Europe PMC4
2004 Wang, J., Nation, R., Evans, A. M., & Cox, S. (2004). Isolated rat kidney perfused with dextran and bovine serum albumin : a stable model for investigating renal drug handling. Journal of pharmacological and toxicological methods, 49(2), 105-113.
DOI Scopus26 Europe PMC16
2004 Jensen, L. S., Valentine, J., Milne, R. W., & Evans, A. M. (2004). The quantification of paracetamol, paracetamol glucuronide and paracetamol sulphate in plasma and urine using a single high-performance liquid chromatography assay. Journal of Pharmaceutical and Biomedical Analysis, 34(3), 585-593.
DOI Scopus97 WoS85 Europe PMC40
2004 Shackleford, D. M., Nation, R., Milne, R. W., Hayball, P. J., & Evans, A. M. (2004). Stereoselective hepatic disposition of model diastereomeric acyl glucuronides. Journal of Pharmacokinetics and Pharmacodynamics, 31(1), 1-27.
DOI Scopus5 WoS5 Europe PMC3
2004 Bain, M. A., Faull, R., Fornasini, G., Milne, R. W., Schumann, R. C., & Evans, A. M. (2004). Quantifying trimethylamine and trimethylamine-N-oxide in human plasma: interference from endogenous quaternary ammonium compounds. Analytical biochemistry, 334(2), 403-405.
DOI Scopus26 WoS24 Europe PMC23
2004 Evans, A. M., Faull, R., Nation, R., Prasad, S., Elias, T., Reuter Lange, S. E., & Fornasini, G. (2004). Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease. Kidney International, 66(4), 1527-1534.
DOI Scopus62 WoS51 Europe PMC40
2004 Wang, J., Nation, R., Evans, A. M., & Cox, S. (2004). Renal excretion mechanisms of the antiviral nucleoside analogue AM 188 in the isolated perfused rat kidney. Clinical and Experimental Pharmacology and Physiology, 31(1-2), 29-34.
DOI Scopus5 WoS5 Europe PMC2
2003 Karpf, D. M., Kirkegaard, A. L., Evans, A. M., Nation, R., Hayball, P. J., & Milne, R. W. (2003). Effect of ketoprofen and its enantiomers on the renal disposition of methotrexate in the isolated perfused rat kidney. Journal of pharmacy and pharmacology, 55(12), 1641-1646.
DOI Scopus7 WoS4 Europe PMC5
2003 Fornasini, G., & Evans, A. M. (2003). Analysis of free carnitine in plasma of ESRD patients undergoing chronic dialysis : what is the best assay?. Dialysis and Transplantation, 32(6), S2-S12.
Scopus13 WoS13
2003 Evans, A. M. (2003). Dialysis-related carnitine disorder and levocarnitine pharmacology. American journal of kidney diseases, 41(4 SUPPL. 4), S13-S26.
DOI Scopus113 WoS96 Europe PMC70
2003 Agatonovic Kustrin, S., Evans, A. M., & Alany, R. (2003). Prediction of corneal permeability using artificial neural networks. Pharmazie, 58(10), 725-729.
Scopus8 WoS6 Europe PMC3
2003 Lucas, A. N., Nation, R. L., Milne, R. W., Reynolds, G. D., & Evans, A. M. (2003). The effects of phytoestrogenic isoflavones on the formation and disposition of paracetamol sulfate in the isolated perfused rat liver. Journal of Pharmacy and Pharmacology, 55(5), 639-646.
DOI Scopus5 WoS4 Europe PMC5
2003 Lucas, A. N., Nation, R., Milne, R. W., Reynolds, G. D., & Evans, A. M. (2003). The effects of phytoestrogenic isoflavones on the formation and disposition of paracetamol sulfate in the isolated perfused rat liver. Journal of pharmacy and pharmacology.
DOI
2003 Evans, A. M., & Fornasini, G. (2003). Pharmacokinetics of L-Carnitine. Clinical pharmacokinetics, 42(11), 941-967.
DOI Scopus270 WoS248 Europe PMC189
2003 Lucas, A. N., Brogan, L. R., Nation, R., Evans, A. M., & Shackleford, D. (2003). The effects of the phytoestrogenic isoflavone genistein on the hepatic disposition of preformed and hepatically-generated gemfibrozil-1-O-acyl glucuronide in the isolated perfused rat liver. Journal of pharmacy and pharmacology, 55(10), 1433-1439.
DOI Scopus2 WoS1
2001 Evans, A. M. (2001). Comparative pharmacology of s(+)- ibuprofen and (RS)- ibuprofen. Clinical rheumatology, 20(1S), 9-14.
DOI Scopus152 WoS118 Europe PMC69
2001 Shackleford, D. M., Hayball, P. J., Reynolds, G. D., Hamon, D., Evans, A. M., Milne, R. W., & Nation, R. L. (2001). A Small-Scale Synthesis and Enantiomeric Resolution of (RS)-[1-14C]-2-Phenylpropionic Acid and Biosynthesis of Its Diastereomeric Acyl Glucuronides. Journal of labelled compounds and radiopharmaceuticals, 44(3), 225-234.
DOI Scopus10 WoS9
2001 Strindelius, L. C., Nation, R. L., Evans, A. M., Cabot, J. L., & Corbett, K. M. (2001). Effect of organic cations on the renal tubular secretion of pseudoephedrine in the rat. Clinical and Experimental Pharmacology and Physiology, 28(1-2), 43-47.
DOI Scopus4 WoS2 Europe PMC2
2000 Evans, A. M. (2000). Influence of dietary components on the gastrointestinal metabolism and transport of drugs. Therapeutic Drug Monitoring, 22(1), 131-136.
DOI Scopus139 WoS106 Europe PMC65
2000 McKinnon, R. A., & Evans, A. M. (2000). Cytochrome P450 2: pharmacogenetics. Australian journal of hospital pharmacy, 30(3), 102-105.
DOI Scopus9
2000 Mancinelli, A., Longo, A., Nation, R. L., & Evans, A. M. (2000). Disposition of L-carnitine and its short-chain esters, acetyl-L-carnitine and propionyl-L-carnitine, in the rat isolated perfused liver. Drug Metabolism and Disposition, 28(12), 1401-1404.
DOI Scopus7 WoS7 Europe PMC4
2000 McKinnon, R. A., & Evans, A. M. (2000). Cytochrome P450 3. Clinically significant drug interactions. Australian journal of hospital pharmacy, 30(4), 146-149.
DOI Scopus14
2000 Milne, R. W., LarsenLA., Jorgensen, K. L., Bastlund, J. F., Stretch, G. L., & Evans, A. M. (2000). Hepatic disposition of fexofenadine: influence of the transport inhibitors erythromycin and dibromosulphothalein.. Pharmaceutical research, 17(12), 1511-1515.
DOI Scopus38 WoS29 Europe PMC20
2000 Pace, S., Longo, A., Toon, S., Rolan, P., & Evans, A. M. (2000). Pharmacokinetics of propionyl- l-carnitine in humans: evidence for saturable tubular reabsorption. British journal of clinical pharmacology, 50(5), 441-448.
DOI Scopus30 WoS25 Europe PMC15
2000 Evans, A., Faull, R., Fornasini, G., Lemanowicz, E., Longo, A., Pace, S., & Nation, R. (2000). Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis. Clinical Pharmacology & Therapeutics, 68(3), 238-249.
DOI Scopus76 WoS69 Europe PMC55
2000 Sabordo, L., Sallustio, B., Evans, A., & Nation, R. (2000). Hepatic disposition of the acyl glucoronide 1-O-gemfibrozil--D-glucoronide: Effects of clofibric acid, acetaminophen, and acetaminophen glucuronide. Journal of Pharmacology and Experimental Therapeutics, 295(1), 44-50.
DOI Scopus15 WoS15 Europe PMC9
2000 Sallustio, B., Sabordo, L., Evans, A., & Nation, R. (2000). Hepatic disposition of electrophilic acyl glucuronide conjugates. Current Drug Metabolism, 1(2), 163-180.
DOI Scopus88 WoS76 Europe PMC58
1999 Sabordo, L., Sallustio, B., Evans, A., & Nation, R. (1999). Hepatic disposition of the acyl glucuronide1-0-gemfibrozil-β-D-glucuronide effects of dibromosulfophthalein in membrane transport and aglycone formation. Journal of Pharmacology and Experimental Therapeutics, 288(2), 414-420.
DOI Scopus29 WoS26 Europe PMC16
1999 Evans, A. M., Obrien, J., & Nation, R. L. (1999). Application of a loading washout method for investigating the hepatocellular efflux of a hepatically-generated metabolite, morphone-3-glucuronide. Journal of pharmacy and pharmacology, 51(11), 1289-1297.
DOI Scopus6 WoS5 Europe PMC2
1999 Stretch, G. L., Nation, R. L., Evans, A. M., & Milne, R. W. (1999). Organ perfusion techniques in drug development. Drug Development Research, 46(3-4), 292-301.
DOI Scopus13 WoS9
1998 Nation, R. L., Evans, A. M., Ottaway, J. L., Shanahan, K. M., & Hsyu, P. (1998). Effect of cationic drugs on the renal secretion of ranitidine in the rat isolated perfused kidney. Clinical and Experimental Pharmacology and Physiology, 25(1), 33-37.
DOI Scopus4 WoS3
1997 Milne, R. W., Jensen, R. H., Larsen, C., Evans, A. M., & Nation, R. L. (1997). Comparison of the disposition of hepatically-generated morphine-3-glucuronide and morphine-6-glucuronide in isolated perfused liver from the guinea pig. Pharmaceutical Research, 14(8), 1014-1018.
DOI Scopus17 WoS14 Europe PMC9
1997 Evans, A. M., Mancinelli, A., & Longo, A. (1997). Excretion and metabolism of propionyl-L-carnitine in the isolated perfused rat kidney. Journal of Pharmacology and Experimental Therapeutics, 281(3), 1071-1076.
DOI Scopus10 WoS11 Europe PMC7
1997 Nation, R. L., Evans, A. M., & Shanahan, K. M. (1997). Disposition of morphine in the rat isolated perfused kidney: concentration ranging studies. Journal of Pharmacology and Experimental Therapeutics, 282(3), 1518-1525.
DOI Scopus17 WoS15 Europe PMC10
1997 Nation, R. L., Evans, A. M., & O'Brien, J. A. (1997). Effects of albumin on the disposition of morphine and morphine-3-glucuronide in the rat isolated perfused liver.. Clinical and Experimental Pharmacology and Physiology, 24(2), 143-148.
DOI Scopus1 WoS2 Europe PMC1
1996 Evans, A. M. (1996). Membrane transport as a determinant of the hepatic elimination of drugs and metabolites. Clinical and Experimental Pharmacology and Physiology, 23(10-11), 970-974.
DOI Scopus29 WoS26 Europe PMC23
1996 O'Brien, J. A., Nation, R. L., & Evans, A. M. (1996). The disposition of morphine and morphine-3-glucuronide in the isolated perfused rat liver: effects of altered perfusate flow. Journal of Pharmacy and Pharmacology, 48(5), 498-504.
DOI Scopus9 WoS8 Europe PMC7
1996 Evans, A. M. (1996). Chirality and the actions of anti-inflammatory drugs. British Veterinary Journal, 152(2), 135-138.
DOI Scopus2 WoS2
1996 Evans, A. M. (1996). Pharmacodynamics and pharmacokinetics of the profens: Enantioselectivity, clinical implications, and special reference to S(+)-ibuprofen. Journal of Clinical Pharmacology, 36(12 SUPPL.), 7S-15S.
Scopus96 Europe PMC32
1996 Evans, A. M. (1996). Pharmacodynamics and Pharmacokinetics of the Profens: Enantioselectivity, Clinical Implications, and Special Reference to S(+)-Ibuprofen. Journal of clinical pharmacology, 36(S12), 7-15.
DOI
1996 Sallustio, B., Fairchild, B., Shanahan, K., Evans, A., & Nation, R. (1996). Disposition of gemfibrozil and gemfibrozil acyl glucuronide in the rat isolated perfused liver. Drug Metabolism and Disposition, 24(9), 984-989.
DOI Scopus34 WoS29 Europe PMC15
1995 Evans, A. M., & Shanahan, K. M. (1995). The disposition of morphine and its metabolites in the in-situ rat isolated-perfused liver. Journal of Pharmacy and Pharmacology, 47(4), 333-339.
DOI Scopus38 WoS34 Europe PMC24
1995 Sansom, L. N., & Evans, A. M. (1995). What is the true clinical significance of plasma-protein binding displacement interactions. Drug Safety, 12(4), 227-233.
DOI Scopus85 WoS69 Europe PMC51
1995 Laslett, T. J., Alvarez, F., Nation, R. L., Evans, A. M., Scott, S. D., & Stupans, I. (1995). Effect of cyclophosphamide administration on the activity and relative content of hepatic P4502D1 in rat. Xenobiotica, 25(10), 1031-1039.
DOI Scopus5 WoS4 Europe PMC5
1995 Mancinelli, A., Longo, A., Shanahan, K., & Evans, A. M. (1995). Disposition of L-carnitine and acetyl-L-carnitine in the isolated-perfused rat kidney. Journal of pharmacology and experimental therapeutics, 274(3), 1122-1128.
DOI Scopus33 WoS30 Europe PMC22
1995 Evans, A. M., & Shanahan, K. M. (1995). Sex differences in the oxidative and conjugative metabolism of morphine in the rat isolated perfused liver. Pharmaceutical sciences, 1(11), 535-538.
DOI Scopus2
1993 Hussein, Z., Evans, A. M., & Rowland, M. (1993). Physiologic models of hepatic drug clearance: influence of altered protein-binding on the elimination of diclofenac in the isolated-perfused rat-liver. Journal of pharmaceutical sciences, 82(9), 880-885.
DOI WoS21
1993 Evans, A. M., Hussein, Z., & Rowland, M. (1993). Influence of albumin on the distribution and elimination kinetics of diclofenac in the isolated perfused-rat-liver: analysis by the impulse-response technique and the dispersion model. Journal of pharmaceutical sciences, 82(4), 421-428.
DOI WoS55
1993 Chou, C. H., Evans, A. M., Fornasini, G., & Rowland, M. (1993). Relationship between lipophilicity and hepatic dispersion and distribution for a homologous series of barbiturates in the isolated perfused in situ rat liver. Drug metabolism and disposition, 21(5), 933-938.
DOI Scopus51 WoS50 Europe PMC39
1992 Diaz Garcia, J. M., Evans, A. M., & Rowland, M. (1992). Application of the axial dispersion model of hepatic drug elimination to the kinetics of diazepam in the isolated perfused rat liver. Journal of pharmakinetics and biopharmaceutics, 20(1), 171-193.
DOI Scopus52 WoS49 Europe PMC36
1992 Evans, A. M. (1992). Enantioselective pharmacodynamics and pharmacokinetics of chiral non-steroidal anti-inflammatory drugs. European Journal of Clinical Pharmacology, 42(3), 237-256.
DOI Scopus217 WoS204 Europe PMC132
1991 EVANS, A. M., HUSSEIN, Z., & ROWLAND, M. (1991). A 2-COMPARTMENT DISPERSION MODEL DESCRIBES THE HEPATIC OUTFLOW PROFILE OF DICLOFENAC IN THE PRESENCE OF ITS BINDING-PROTEIN. JOURNAL OF PHARMACY AND PHARMACOLOGY, 43(10), 709-714.
DOI WoS36
1991 Evans, A. M., Nation, R. L., Sansom, L. N., Bochner, F., & Somogyi, A. A. (1991). Effect of racemic ibuprofen dose on the magnitude and duration of platelet cyclo-oxygenase inhibition: relationship between inhibition of thromboxane production and the plasma unbound concentration of S(+)-ibuprofen.. British journal of clinical pharmacology, 31(2), 131-138.
DOI Scopus52 WoS56 Europe PMC36
1990 Evans, A. M., Nation, R. L., Sansom, L. N., Bochner, F., & Somogyi, A. A. (1990). The relationship between the pharmacokinetics of ibuprofen enantiomers and the dose of racemic ibuprofen in humans. Biopharmaceutics Drug Disposition, 11(6), 507-518.
DOI Scopus46 WoS49 Europe PMC26
1990 Nation, R. L., Evans, A. M., & Milne, R. W. (1990). Pharmacokinetic drug interactions with phenytoin (part II). Clinical pharmacokinetics, 18(2), 131-150.
DOI Scopus53 WoS52 Europe PMC28
1990 Evans, A. M., & Green, K. L. (1990). The action of dopamine receptor antagonists on the secretory response of the cockroach salivary gland in vitro. Comparative Biochemistry and Physiology Part C Comparative, 97(2), 283-286.
DOI Scopus25 WoS27 Europe PMC6
1990 Evans, A. M., & Green, K. L. (1990). Characterization of the dopamine receptor mediating the hyperpolarization of cockroach salivary gland acinar cells in vitro. British Journal of Pharmacology, 101(1), 103-108.
DOI Scopus36 WoS37 Europe PMC30
1990 Evans, A. M., & Green, K. L. (1990). The effect of domperidone on the electrical response of cockroach salivary gland acinar cells. European Journal of Pharmacology, 191(3), 465-469.
DOI Scopus2 WoS3 Europe PMC1
1990 Nation, R. L., Evans, A. M., & Milne, R. W. (1990). Pharmacokinetic drug interactions with phenytoin (Part 1). Clinical pharmacokinetics, 18(1), 37.
DOI Scopus128 WoS113 Europe PMC84
1989 Evans, A. M., Nation, R. L., & Sansom, L. N. (1989). Lack of effect of cimetidine on the pharmacokinetics of R(-)- and S(+)-ibuprofen. British journal of clinical pharmacology, 28(2), 132-149.
DOI Scopus21 WoS23 Europe PMC16
1989 Evans, A. M., Nation, R. L., Sansom, L. N., Bochner, F., & Somogyi, A. A. (1989). Stereoselective plasma protein binding of ibuprofen enantiomers. European journal of clinical pharmacology, 36(3), 283-290.
DOI Scopus93 WoS91 Europe PMC68
1988 Evans, A. M., Nation, R. L., Sansom, L. N., Bochner, F., & Somogyi, A. A. (1988). Stereoselective drug disposition: potential for misinterpretation of drug disposition data. British journal of clinical pharmacology, 26(6), 771-780.
DOI Scopus58 WoS53 Europe PMC47

Year Citation
2009 Rao, S., Song, Y., Peddie, F., & Evans, A. M. (2009). Development and evaluation of a novel design of buccal mucoadhesive patches. In Teams for tomorrow. Canberra, Australia: APSA.
2005 Barnes, T. J., Er, Y., Tan, A., Prestidge, C. A., & Evans, A. M. (2005). Colloidal stability of lecithin liposomes. In Smart Solutions Doing More with Less, Chemeca 2005: Conference Proceedings. Australia: Institution of Engineers, IChemE, SCENZ and RACI, with University of Queensland.
2004 Kong, L., Gao, W., Evans, A. M., Wang, B., & Milne, R. W. (2004). Influence of geometrical design and flow conditions on the performance of a microatomiser. In Proceedings of ESDA 2004: 7th Biennial Conference on Engineering Systems Design and Analysis Vol. 3 (pp. 47-52). USA: American Society of Mechanical Engineers.
DOI
2000 Shackleford, D. M., Evans, A. M., Hayball, P. J., Milne, R. W., & Nation, R. L. (2000). Stereoselective biliary excretion of the hepatically-generated acyl glycuronide metabolites of (R)- and (S)-2-phenylpropionic acid. In proceedings of the Millennial World Congree of Pharmaceutical Sciences.
2000 Lucas, A. N., Evans, A. M., Milne, R. W., & Nation, R. L. (2000). The effects of phytoestrogenic isoflavones on the hepatic disposition of paracetamol. In Proceedings of the APSA 2000 Annual Conference.
2000 Evans, A. M., Nation, R. L., Fornasini, G., Pace, S., Lemanowicz, E., & Faull, R. (2000). Pharmacokinetics of L-Carnitine (LC) after single and multiple intravenous administration to chronic haemodialysis patients. In Proceedings of the Millennial World Congress of Pharmaceutical Sciences.
2000 Evans, A. M. (2000). Interactions between drugs and natural therapies. In Proceedings of the APSA 2000 Annual Conference.
2000 Mojarrabi, B., Lucas, A. N., Beck, A. R., Evans, A. M., Milne, R. W., & Nation, R. L. (2000). Validation of a Caco-2 cell monolayer systenm to investigate transport via P-glycoprotein. In Proceedings of the APSA 2000 Annual Conference.
2000 Nation, R. L., Evans, A. M., Fornasini, G., Pace, S., Longo, A., & Faull, R. (2000). Disposition of endogenous L-Carnitine and acetyl-l-carnitine in chronic haemodialysis patients. In Proceedings of the Millennial World Congree of Pharmaceutical Sciences.
2000 Loh, S. F., McKinnon, R. A., & Evans, A. M. (2000). The in vitro antiproliferative action of flurbiprofen on a melanoma cell line. In Proceedings of the APSA 2000 Annual Conference.
1999 Milne, R. W., Jorgensen, K. L., Stretch, G. L., & Evans, A. M. (1999). Hepatic disposition of fexofenadine: the influence of perfusate concentration. In APSA.
1999 Walkley, C. R., Evans, A. M., & McKinnon, R. A. (1999). The antiproliferative effect of ketoprofen on HaCaT cells is non-enantiomer specific. In Proceedings of APSA. APSA.
1999 Khalil, V., Evans, A. M., Hayball, P. J., Milne, R. W., & Nation, R. L. (1999). Disposition of gemfibrozil and its acyl glucuronide in the isolated perfused rat kidney. In APSA.
1999 Nation, R. L., Evans, A. M., Fornasini, G., Pace, S., Longo, A., & Faull, R. (1999). Disposition of endogenous L-carnitine and acetyl-L-carnitine in chronic haemodialysis patients. In APSA. APSA.
1999 Shackleford, D. M., Evans, A. M., Hayball, P. J., Milne, R. W., & Nation, R. L. (1999). Stereoselective excretion of the hepatically-generated acyl glucuronide metabolites of (R)-(-)-and (S)-(+)-2-phenylpropionic acid. In APSA.
1999 Sabordo, L., Sallustio, B., Evans, A. M., & Nation, R. L. (1999). Effect of clofibric acid and paracetamol on the hepatic disposition of 1-0-gemfibrozil-beta-D. In ASCEPT. ASCEPT.
1999 Loh, S. F., McKinnon, R. A., & Evans, A. M. (1999). The in vitro antiproliferative action of NSAIDs on HaCaT cell line. In Proceedings of APSA. APSA.
1999 Evans, A. M., Nation, R. L., Fornasini, G., Pace, S., Lemanowicz, E., & Faull, R. (1999). Pharmacokinetics of L-carnitine after single and multiple intravenous administration to chronic haemodialysis patients. In APSA. APSA.
1999 Stretch, G. L., Nation, R. L., Evans, A. M., Hayball, P. J., & Milne, R. W. (1999). Extensive tubular secretion of zidovudine and its ether-glucuronide in the isolated perfused rat kidney. In APSA.
1999 Walkley, C. R., Evans, A. M., & McKinnon, R. A. (1999). NSAID chemoprevention: A study of the cellular and molecular effects of ketoprofen on skin. In Proceedings of ASCEPT. ASCEPT.
1998 Sabordo, L., Sallustio, B., Evans, A. M., & Nation, R. L. (1998). Effect of organic anions on the hepatic dispsoition of 1-0-gemfibrozil-beta-D-glucuronide. In Proceedings of 5th International ISSX Meeting. USA: ISSX.
1998 Sabordo, L., Sallustio, B., Evans, A. M., & Nation, R. L. (1998). Effect of dibromosulfophthalein (DBSP) on the covalent binding of diclofenac to liver tissue proteins. In Proceedings of ASCEPT. Australia: ASCEPT.
1998 Ng, D., Evans, A. M., Milne, R. W., & Nation, R. L. (1998). The renal disposition of methotrexate in the isolated perfused rat kidney: concentration ranging and the influence of probenecid. In Proceedings of ASCEPT. Australia: ASCEPT.
1998 Milne, R. W., Evans, A. M., Nation, R. L., Shanahan, K. M., & Marwood, A. C. (1998). Disposition of morphine and its glucuronide metabolites in the isolated perfused liver of the guinea pig - concentration ranging studies. In Proceedings of the 5th International ISSX Meeting. USA: ISSX.
1998 Shackleford, D. M., Evans, A. M., Hayball, P. J., Milne, R. W., & Nation, R. L. (1998). Pharmacokinetics of 2-phenylpropionic acid enantiomers in the single-pass isolated perfused rat liver. In Proceedings of ASCEPT. AUSTRALIA: ASCEPT.
1998 Khalil, V., Evans, A. M., Hayball, P. J., Milne, R. W., Nation, R. L., Sallustio, B., & Stretch, G. L. (1998). Functional parameters of the isolated perfused kidney with dextran. In Proceedings of ASCEPT. Australia: ASCEPT.
1997 Nation, R. L., Evans, A. M., & Shanahan, K. M. (1997). Disposition of morphine in the rat isolated perfused kidney: concentration-ranging studies. In International Society for Study of Xenobiotics Proceedings: 8th North American ISSX Meeting. ISSX.
1996 Evans, A. M. (1996). Pharmacodynamics and pharmacokinetics of the profens: Enantioselectivity, clinical implications, and special reference to S(+)-ibuprofen. In JOURNAL OF CLINICAL PHARMACOLOGY Vol. 36 (pp. S7-S15). AUSTRIA, GOING: LIPPINCOTT-RAVEN PUBL.
WoS73
1991 Diaz-Garcia, J. M., Evans, A. M., & Rowland, M. (1991). Application of the axial dispersion model to the kinetics of diazepam in the single-pass perfused in-situ rat liver. In Journal of Pharmacy and Pharmacology Supplement Vol. 43 (pp. 21).

Year Citation
2008 McKinnon, R., & Evans, A. (2008). AU2008217012, NSAID-containing topical formulations that demonstrate chemopreventive activity.

  • PK analysis research services for clinical study DTX-SPL8783, Starpharma, 04/07/2016 - 30/12/2020

Connect With Me

External Profiles

Other Links